Medication-induced hypophosphatemia: a review
- PMID: 20356849
- DOI: 10.1093/qjmed/hcq039
Medication-induced hypophosphatemia: a review
Abstract
Hypophosphatemia (serum phosphorus concentration <2.5 mg/dl, 0.8 mmol/l), although rare in the general population, is commonly observed in hospitalized patients and may be associated with drug therapy. In fact, hypophosphatemia frequently develops in the course of treatment with drugs used in every-day clinical practice including diuretics and bisphosphonates. Proper diagnostic approach of patients with low serum phosphorus concentrations should involve a detailed medical history with special attention to the recent use of medications. The clinical manifestations of drug-induced hypophosphatemia are usually mild but might also be severe and potentially life-threatening. This review aims at a thorough understanding of the underlying pathophysiological mechanisms and risk factors of drug therapy-related hypophosphatemia thus allowing prevention and effective intervention strategies.
Similar articles
-
Severe hypophosphatemia in hospitalized patients.Arch Intern Med. 1988 Jan;148(1):153-5. Arch Intern Med. 1988. PMID: 3122679
-
Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation.Bone Marrow Transplant. 2000 May;25(9):1015-6. doi: 10.1038/sj.bmt.1702407. Bone Marrow Transplant. 2000. PMID: 10800074
-
Hypophosphatemia in hospitalized patients.JAMA. 1979 Jul 13;242(2):163-4. JAMA. 1979. PMID: 448890
-
Drug-Induced Hypophosphatemia: Current Insights.Drug Saf. 2020 Mar;43(3):197-210. doi: 10.1007/s40264-019-00888-1. Drug Saf. 2020. PMID: 31776845 Review.
-
Hypophosphatemia: an update on its etiology and treatment.Am J Med. 2005 Oct;118(10):1094-101. doi: 10.1016/j.amjmed.2005.02.014. Am J Med. 2005. PMID: 16194637 Review.
Cited by
-
Phosphate level predicts mortality in acute kidney injury patients undergoing continuous kidney replacement therapy and has a U-shaped association with mortality in patients with high disease severity: a multicenter retrospective study.Kidney Res Clin Pract. 2024 Jul;43(4):492-504. doi: 10.23876/j.krcp.23.311. Epub 2024 Jun 13. Kidney Res Clin Pract. 2024. PMID: 38934034 Free PMC article.
-
Evaluation of a Novel Enteral Phosphorus Therapy with Enteral Nutrition during a National Intravenous Sodium Phosphate Shortage.Nutrients. 2024 May 6;16(9):1394. doi: 10.3390/nu16091394. Nutrients. 2024. PMID: 38732640 Free PMC article.
-
A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan.Bone Rep. 2024 Mar 26;21:101754. doi: 10.1016/j.bonr.2024.101754. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38584682 Free PMC article.
-
Incidental Normocalcemic Primary Hyperparathyroidism Presenting With Symptomatic Hypophosphatemia: A Case Report.Cureus. 2023 Aug 30;15(8):e44378. doi: 10.7759/cureus.44378. eCollection 2023 Aug. Cureus. 2023. PMID: 37779800 Free PMC article.
-
Hypophosphatemia in Patients With Multiple Myeloma.Cureus. 2023 Jun 15;15(6):e40487. doi: 10.7759/cureus.40487. eCollection 2023 Jun. Cureus. 2023. PMID: 37342302 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
